Funding Cuts Jeopardize HIV Prevention Programs in South Africa

U.S. funding cuts to South African HIV prevention programs are wreaking havoc just as a new drug, lenacapavir, is prepared for distribution, according to a recent report. South Africa, home to the world's largest population of HIV-infected individuals, is seeing critical services dismantled after the U.S. slashed 17% of its HIV budget.

The report from Physicians for Human Rights highlights the financial wastage from abandoned research and health infrastructure efforts, compromising the rollout of lenacapavir—a significant twice-yearly injectable HIV prevention drug. The United States had previously funded community outreach and peer education programs on HIV prevention options, crucial for awareness about lenacapavir.

The funding cuts could have dire consequences for underserved groups, including LGBTQI communities, sex workers, and young people, warns Yvette Raphael from Advocates for the Prevention of HIV in South Africa. Despite official claims of maintained global HIV aid levels, actual HIV testing and diagnoses have notably declined.